Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition ...

Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition ...

Recent research on hybrid diffuse optics reveals its potential to enhance blood transfusion monitoring, improving patient ...

A host of AI-powered tools enable this nimble and compact gimbal to keep you (and your friends) in the picture ...

Fabrinet (FN) reports a 17% year-over-year revenue increase and unveils plans for a new facility to support future growth.

New research shows black holes can trigger gas cooling, creating fuel for their own feeding. This process keeps them growing ...

Flow Cytometry MarketThe global flow cytometry market is on the cusp of a remarkable transformation, with projections indicating a substantial surge in market value over the next decade. According to ...

GAAP net income for the second quarter of fiscal year 2025 was $86.6 million, compared to $69.1 million for the second quarter of fiscal year 2024. GAAP net income per diluted share for the second ...

Understanding how tumors change their metabolism to resist treatments is a growing focus in cancer research. As cancer cells adapt to therapies, their metabolism often shifts, which can help them ...

Q2 2025 Management View CEO Seamus Grady highlighted a record quarter for revenue and profitability, with revenue reaching $834 million, up 17% year-over-year and 4% sequentially. Non-GAAP EPS was $2.

CEO Kishore Seendripu highlighted that Q4 2024 results surpassed guidance midpoint with $92.2 million in revenue and a non-GAAP gross margin of 59.1%. He emphasized ongoing strength in customer order ...